Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 9 to 17

Intensive treatment for children with speech sound disorders

Official title: Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

Run by Syracuse University · NCT05929859 · Data updated 2026-11-12

This study tests whether more frequent speech therapy sessions can help school-age children with speech sound disorders improve their speech better than traditional therapy schedules.

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages9 Years to 17 Years
SexAll
Enrollment84 (estimated)
SponsorSyracuse University
Academic / other
Locations1 site (Syracuse, New York)
StatusRecruiting
StartedOctober 26, 2023
Main results expectedFebruary 29, 2028
Study endsFebruary 29, 2028
Registry record updatedJanuary 13, 2026
Trial IDNCT05929859 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are school-age children between 9 and 17 years old who have difficulty producing the sounds /ɹ/ and/or /s/ and meet specific language and hearing criteria.

Probably not a fit

Patients who do not have residual speech sound disorders or who exhibit features of childhood apraxia of speech may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of intensive versus distributed treatment schedules for school-age children with residual speech sound disorders. Participants will be randomly assigned to either a traditional treatment schedule of two sessions per week over eight weeks or an intensive schedule of four sessions per week for four weeks. The study focuses on optimizing motor-based treatments for specific speech sounds, particularly /ɹ/ and /s/, to enhance learning outcomes. By investigating the impact of treatment intensity on speech sound learning, the trial seeks to address practical barriers in therapy delivery.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatment strategies for children with speech sound disorders, improving their communication skills and overall quality of life.

How similar studies have gone: While the approach of varying treatment intensity is being explored, this specific comparison of intensive versus distributed schedules in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Must speak American English as a dominant language.
* Must have began learning English by at least the age of 3 years.
* Must be between 9;0 to 17;11 years of age.
* Must have reported difficulty with /ɹ/ and/or /s/ production
* Must pass pure tone hearing screening at 25 dB at 1000, 2000, and 4000 Hz.
* Must receive a scaled score of at least 5 on the Listening Comprehension and Story Retelling subtests of the Test of Integrated Language and Literacy Skills (TILLS)
* Must receive a percentile score of 5 or below on the Goldman-Fristoe Test of Articulation-3 (GFTA-3) Sounds in Words subtest.
* Must have 1 scorable response with 5+ consecutive correct /pataka/ with \> 3.4 syllables per second in the MRR-Tri task of the Maximum Performance Tasks OR must demonstrate no childhood apraxia of speech (CAS-only) features in BOTH articulatory and rate/prosody domains of the ProCAD.
* Must score \<40% accurate on /ɹ/ and/or /s/ probes assessing these sounds at the word level.
* Must express a desire to modify their speech.

Exclusion Criteria:

* Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, or brain injury.
* Must not have current cleft palate or voice disorder.

Where it's running

  • Syracuse University
    Syracuse, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Jonathan Preston, PhD — Syracuse University
  • Study coordinator: Jonathan Preston, PhD
  • Email: jopresto@syr.edu
  • Phone: 315-443-1351

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.